Notícias

SK Hynix filed to offer ADRs in the US as it seeks to raise roughly $28 billion amid the AI boom.

CNBC’s Jim Cramer strongly endorsed a potential merger between Honeywell International‘s (NASDAQ:HON) spinoff Solstice Advanced Materials Inc. (NASDAQ:SOLS) and Element Solutions Inc. (NYSE:ESI) on Monday. Cramer Backs Megamerger Reacting to financial reports of a $27 billion tie-up, Cramer stated that shares of both companies could “go higher” because the combination “would create a chemical tech powerhouse.” He ultimately labeled the ongoing negotiations a “really smart deal.” Solstice to merg

Microsoft and Chipotle both crushed the market over the past decade, but their recent stumbles reveal two very different problems and two very different bets on what comes next.

Rep. Dan Meuser and Rep. Gil Cisneros disclosed purchases of SpaceX stock days after the company's June 12 IPO, raising questions about their committee roles

Data center provider Csquare is targeting a valuation of up to $4.18 billion in its U.S. ‌initial public offering, riding a wave of investor enthusiasm ‌for companies expected to benefit from the AI boom. The Dallas-based company said on ​Monday it aims to raise up to $1.35 billion in the IPO by offering 50 million shares at $23 to $27 apiece. New listings in the U.S. have picked up after geopolitical tensions briefly cooled ‌issuance earlier this year, ⁠while surging demand for AI computing infrastructure has boosted investor interest in data center operators.

(Bloomberg) -- Csquare Inc., a data center company backed by Brookfield Corp., is seeking to raise as much as $1.35 billion in a US initial public offering.Most Read from BloombergGreece Offers Bounty to Catch Ravenous Fish Lured by Warming SeaOil, Gas Tankers Cross Hormuz Via Oman-Side Route After U-TurnsThe Tanker Tycoon Making Millions on Hormuz Shuttle RunsModi’s Flagship Biofuel Push Faces Backlash From MotoristsOil’s Supply Wave, Tumbling Prices Rekindle Fears of Global GlutThe company is

Merger Discussions Could Create Major Specialty Chemicals GroupSolstice Advanced Materials (NASDAQ:SOLS), the specialty chemicals business spun off from Honeywell (NASDAQ:HON), is reportedly in discussions to merge with Element Solutions Inc (NYSE:ESI) in a transaction that would value the combined company at approximately $27 billion in enterprise value, according to the Financial Times. People familiar with the matter told the publication that the companies are negotiating a merger of equals a

Honeywell spinoff Solstice Advanced Materials is in talks to merge with Element Solutions in a deal ‌that could create a chemicals company valued at about $27 ‌billion including debt, the Financial Times reported on Monday. The talks happen as both ​companies seek to capitalize on growing demand for specialty chemicals used in AI data centers and semiconductor manufacturing. Solstice and Element Solutions are discussing a merger of equals and a deal, likely to be ‌mostly stock with ⁠some cash, could come together as soon as this week, the FT report said, citing people familiar ⁠with the talks.

Honeywell spin-off Solstice Advanced Materials is in talks to merge with Element Solutions, potentially striking a deal that would create a ...

So far, the results haven't lived up to the hype.

KeyBanc maintained its ‘Overweight’ rating despite lowering its price target.

The spinoff has investors taking a fresh look at the sector, now split between old-school telecom and the AI-heavy giants crowding into the space.

Enterprise customers have begun to doubt the burdensome cost of pay-per-use token consumption and are looking to cheaper models.

The debate over a possible Tesla-SpaceX merger is getting harder to ignore.

SpaceX completed a record IPO about three weeks ago.

Starbucks (NASDAQ:SBUX) and Chipotle Mexican Grill (NYSE:CMG) just delivered two of the most instructive turnaround updates in restaurants. Starbucks posted its clearest inflection yet under Brian Niccol. Chipotle, still working through a full year of negative comps, leaned harder on unit growth and menu innovation. Same sector, two very different scoreboards. Coffee Traffic Comes Back. ... Starbucks vs Chipotle: Two Restaurant Titans, Two Playbooks, Only One Winner

Diamondback Energy Inc. (NASDAQ:FANG) is one of the 10 Most Undervalued NASDAQ Stocks to Buy Right Now. On July 1, Viper Energy, a subsidiary of Diamondback Energy, announced the completion of its acquisition of Riverbend Oil & Gas IX, LLC. The transaction involved the transfer of mineral and royalty interests to Viper in exchange for […]

OpenAI may not go public until 2027, but there are already many ways to own it indirectly.

One seasoned Wall Street expert is very bearish on SpaceX and the stock market in general.

OpenAI filed for an IPO this June.

The worst-performing "Magnificent Seven" stock of 2026 owns about a quarter of one of the biggest IPOs in the pipeline.

Anthropic will likely start trading in the coming months.

SpaceX stock is 19% off its peak.

The space-launch company is shelling out serious dough to pull this deal off, but it's arguably worth it.

Investing.com -- Deutsche Telekom’s recent share price decline appears overdone, according to UBS, which argues that investor concerns over a potential merger with T-Mobile US and rising competition in the U.S. wireless market have overshadowed the company’s strong operating performance.

OpenAI and Anthropic appear uniquely positioned to become the market's next blockbuster listings.

Trump expects Musk may join Micron and Dell in backing child investment accounts launching July 4.

It operates about 3,300 restaurants across the US and Canada, with annual systemwide sales of $4.3bn .

OpenAI is trying to avoid a volatile IPO. It probably won't succeed.

By Karen Roman CareDx, Inc. (Nasdaq: CDNA) said it completed the acquisition of Naveris, which includes its leading product, NavDx, a blood-based test for viral-mediated cancer detection including human papillomavirus, and associated head and neck and anal cancers. NavDx is the first and only Medicare-covered test for HPV-driven head and neck and anal cancer molecular […] The post CareDx Acquires Naveris, Extends Leadership into High-Growth Specialty Oncology appeared first on ExecEdge.